Uncategorized

Make an Impact with Cure SMA’s Mission, Milestones, Momentum Campaign

November 1, 2024
Posted in , , ,

We’re kicking off our Mission, Milestones, Momentum Year-End Campaign with an incredible $50,000 matching gift. In honor of Hunter Rhodes, living with SMA, the Johns […]

Read More ›

Fall 2024 Walk-n-Roll Registration is Open

May 31, 2024
Posted in , ,

Cure SMA’s Fall 2024 Walk-n-Roll events are open! By participating in our Walk-n-Roll, you can make a real difference in the lives of those affected by […]

Read More ›

Registration is Open for the 2024 Annual SMA Conference!

December 7, 2023
Posted in

We are excited to announce that registration is now open for the 2024 Annual SMA Conference, which will be held at the JW Marriott Austin in […]

Read More ›

Biohaven Completes Enrollment in Pivotal Phase 3 Study

September 19, 2023
Posted in , , ,

Recently, Biohaven released a statement on the completed enrollment of their pivotal Phase 3 Study of Taldefgrobep Alfa in people with SMA. Check out Biohaven’s […]

Read More ›

The State of SMA – Toward Improved Therapeutics and Care

September 7, 2023
Posted in

Each year, Cure SMA collaborates with our Scientific Advisory Board to plan a Special Session that will be held during the Annual Research & Clinical […]

Read More ›

Thank You for an Amazing 2023 Annual SMA Conference!

July 24, 2023
Posted in , ,

Thank you to everyone who attended the 2023 Annual SMA Conference at Disney’s Yacht & Beach Club in Orlando, Florida! It was an impactful weekend […]

Read More ›

Cure SMA Applauds Federal Agency Decision that Should Lead to Better Insurance Coverage for Seat Elevation Systems in Power Wheelchairs

May 25, 2023
Posted in , ,

Thanks to the advocacy of individuals with spinal muscular atrophy (SMA) and others, the Centers for Medicare and Medicaid Services (CMS) now considers seat elevation […]

Read More ›

Biogen Announces New Updates Across its SMA Research Program at 2023 MDA Conference

April 11, 2023
Posted in

First patient treated in the ASCEND study evaluating the potential benefit of investigational higher dose nusinersen in children, teens and adults previously treated with Evrysdi® (risdiplam) […]

Read More ›

Cure SMA Announces Expanded Phase 8 of SMA Industry Collaboration

April 4, 2023
Posted in

Cure SMA is pleased to announce the launch of an expanded Phase 8 of our SMA Industry Collaboration. The SMA Industry Collaboration is a multi-faceted […]

Read More ›

Cure SMA Welcomes New Care Center Network Site!

March 22, 2023
Posted in

We’d like to give a warm welcome to Children’s Hospital Colorado as a newly added Cure SMA Care Center! Thank you to Loree, Ward and […]

Read More ›
Scroll to Top